Patent details

Basic Information

Publication number:

EP2094247

PCT Application Number:

US2007021475

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP078393337

PCT Publication Number:

WO2008051363

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

STABLE POLYPEPTIDE FORMULATIONS

French Title of Invention:

FORMULATIONS STABLES DE POLYPEPTIDE

German Title of Invention:

STABILE POLYPEPTID-FORMULIERUNGEN

SPC Number:

Dates

Filing date:

05/10/2007

Grant date:

29/06/2022

EP Publication Date:

02/09/2009

PCT Publication Date:

02/05/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/06/2022

EP B1 Publication Date:

29/06/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/10/2022

Expiration date:

05/10/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/06/2022

 

 

Name:

Amgen Inc.

Address:

Patent Operations M/S 28-2-C One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:

CHELIUS, Dirk

Address:

United States (US)

2

Name:

MATSUMURA, Masazumi

Address:

United States (US)

3

Name:

BONDARENKO, Pavel

Address:

United States (US)

4

Name:

MCAULEY, Arnold

Address:

United States (US)

5

Name:

REHDER, Douglas

Address:

United States (US)

Priority

Priority Number:

853181 P

Priority Date:

20/10/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/19; A61K 47/02; A61K 47/26; A61K 9/00; A61K 39/395;

Publication

European Patent Bulletin

Issue number:

202226

Publication date:

29/06/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages